Elevated suppression of tumorigenicity 2 associated with poor outcome in heart failure with preserved ejection fraction

Back

HFA Premium Access

Elevated suppression of tumorigenicity 2 associated with poor outcome in heart failure with preserved ejection fraction

Session: Diagnostics - From epicardial fatty tissue to biomarkers and echocardiography

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor C. Roy (La Louviere, BE)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Doctor Clotilde Roy

Jolimont Lobbes Hospital, La Louviere (Belgium)

1 presentation

0 follower

9 more presentations in this session

Cytokines, Epicardial Adipose Tissue and Diastolic Function in the General Population

Speaker: Associate Professor R. Hullin (Lausanne, CH)

Access

Abstract

The BNP genetic variant rs198389: cardiovascular phenotype and risk in stage A/B heart failure subjects from the STOP-HF Trial

Speaker: Doctor V. Cannone (Parma, IT)

Neurohormonal function across categories of systolic dysfunction in chronic heart failure

Speaker: Doctor A. Aimo (Pisa, IT)

BNP in patients with severe aortic valve stenosis undergoing valve replacement: pathophysiological determinants and long-term impact on mortality

Speaker: Doctor L. Weber (CH)

HF-DACH 2018, Cardiac fibrosis marker GDF-15 is associated with prognosis in treatment naive cancer patients

Speaker: Doctor H. Arfsten (Vienna, AT)

Access

Abstract

Access the full session

Diagnostics - From epicardial fatty tissue to biomarkers and echocardiography

Speakers: Doctor C. Roy, Associate Professor R. Hullin, Doctor V. Cannone, Doctor A. Aimo, Doctor L. Weber...

Access

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources